{"id":4669,"date":"2020-12-21T18:35:41","date_gmt":"2020-12-21T18:35:41","guid":{"rendered":"http:\/\/dev.sunpharma.com\/?page_id=4669"},"modified":"2024-02-15T20:07:13","modified_gmt":"2024-02-15T14:37:13","slug":"ranbaxy-merger-share-holding-pattern","status":"publish","type":"page","link":"https:\/\/dev.sunpharma.com\/he\/ranbaxy-merger-share-holding-pattern\/","title":{"rendered":"Ranbaxy Merger \u2013 Share Holding Pattern"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; fullwidth=&#8221;on&#8221; admin_label=&#8221;Popup &#8211; #undefined&#8221; _builder_version=&#8221;4.7.4&#8243; background_image=&#8221;https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2021\/03\/investor-banner.jpg&#8221; parallax=&#8221;on&#8221; saved_tabs=&#8221;all&#8221; collapsed=&#8221;off&#8221; da_is_popup=&#8221;off&#8221; da_exit_intent=&#8221;off&#8221; da_has_close=&#8221;on&#8221; da_alt_close=&#8221;off&#8221; da_dark_close=&#8221;off&#8221; da_not_modal=&#8221;on&#8221; da_is_singular=&#8221;off&#8221; da_with_loader=&#8221;off&#8221; da_has_shadow=&#8221;on&#8221; da_disable_devices=&#8221;off|off|off&#8221;][et_pb_fullwidth_header title=&#8221;Investor Information&#8221; header_fullscreen=&#8221;on&#8221; button_one_url=&#8221;#visionvalues&#8221; button_two_url=&#8221;#codeofconduct&#8221; _builder_version=&#8221;4.7.4&#8243; title_font=&#8221;|700|||||||&#8221; title_text_color=&#8221;#f7941e&#8221; title_font_size=&#8221;40px&#8221; title_line_height=&#8221;1.2em&#8221; content_font=&#8221;||||||||&#8221; content_text_color=&#8221;#000000&#8243; content_line_height=&#8221;1.8em&#8221; subhead_font=&#8221;||||||||&#8221; subhead_text_color=&#8221;rgba(0,0,0,0.6)&#8221; subhead_font_size=&#8221;22px&#8221; subhead_line_height=&#8221;1.4em&#8221; background_color=&#8221;rgba(255,255,255,0.7)&#8221; custom_button_one=&#8221;on&#8221; button_one_text_size=&#8221;20px&#8221; button_one_text_color=&#8221;#ffffff&#8221; button_one_bg_color=&#8221;#f7941e&#8221; button_one_border_width=&#8221;0px&#8221; button_one_font=&#8221;|||on|||||&#8221; button_one_use_icon=&#8221;off&#8221; custom_button_two=&#8221;on&#8221; button_two_text_size=&#8221;20px&#8221; button_two_text_color=&#8221;rgba(0,0,0,0.7)&#8221; button_two_bg_color=&#8221;#ffffff&#8221; button_two_border_width=&#8221;0px&#8221; button_two_font=&#8221;|||on|||||&#8221; button_two_use_icon=&#8221;off&#8221; button_two_custom_margin=&#8221;||||false|false&#8221; button_two_custom_margin_tablet=&#8221;&#8221; button_two_custom_margin_phone=&#8221;|||1px|false|false&#8221; button_two_custom_margin_last_edited=&#8221;on|desktop&#8221; button_two_custom_padding=&#8221;||||false|false&#8221; background_layout=&#8221;light&#8221; width=&#8221;50%&#8221; width_tablet=&#8221;&#8221; width_phone=&#8221;100%&#8221; width_last_edited=&#8221;on|phone&#8221; animation_style=&#8221;fade&#8221; animation_duration=&#8221;500ms&#8221; animation_delay=&#8221;300ms&#8221; title_font_tablet=&#8221;&#8221; title_font_phone=&#8221;&#8221; title_font_last_edited=&#8221;on|phone&#8221; content_font_tablet=&#8221;&#8221; content_font_phone=&#8221;&#8221; content_font_last_edited=&#8221;on|phone&#8221;]At Sun, we remain committed to creating long term value for our shareholders. In line with this philosophy, we will continue to focus on performance and producing consistent returns.[\/et_pb_fullwidth_header][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; admin_label=&#8221;Popup &#8211; #undefined&#8221; _builder_version=&#8221;4.7.4&#8243; _module_preset=&#8221;default&#8221; da_is_popup=&#8221;off&#8221; da_exit_intent=&#8221;off&#8221; da_has_close=&#8221;on&#8221; da_alt_close=&#8221;off&#8221; da_dark_close=&#8221;off&#8221; da_not_modal=&#8221;on&#8221; da_is_singular=&#8221;off&#8221; da_with_loader=&#8221;off&#8221; da_has_shadow=&#8221;on&#8221; da_disable_devices=&#8221;off|off|off&#8221;][et_pb_row _builder_version=&#8221;4.7.4&#8243; width=&#8221;90%&#8221; max_width=&#8221;2560px&#8221; custom_padding=&#8221;0px||||false|false&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.4.2&#8243;][et_pb_text _builder_version=&#8221;4.7.4&#8243; _module_preset=&#8221;default&#8221; text_text_color=&#8221;#000000&#8243; text_line_height=&#8221;1.8em&#8221; header_font=&#8221;|700|||||||&#8221; header_text_color=&#8221;#f7941e&#8221; header_font_size=&#8221;25px&#8221; header_line_height=&#8221;1.2em&#8221; header_3_font=&#8221;|700|||||||&#8221; header_3_text_color=&#8221;#000000&#8243; header_3_font_size=&#8221;20px&#8221; header_3_line_height=&#8221;1.2em&#8221;]<\/p>\n<h1>Shareholding Pattern<\/h1>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; _builder_version=&#8221;4.7.4&#8243; width=&#8221;90%&#8221; max_width=&#8221;2560px&#8221; custom_padding=&#8221;0px||0px||true|false&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.4.2&#8243;][et_pb_text _builder_version=&#8221;4.7.4&#8243; _module_preset=&#8221;default&#8221; text_text_color=&#8221;#000000&#8243; text_line_height=&#8221;1.8em&#8221; header_font=&#8221;|600|||||||&#8221; header_3_font=&#8221;|700|||||||&#8221; header_3_text_color=&#8221;#000000&#8243; header_3_font_size=&#8221;20px&#8221; header_3_line_height=&#8221;1.2em&#8221;]<\/p>\n<h3>Share Holding 31-12-2014<\/h3>\n<p>Note: Kindly note the revised shareholding pattern format<\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Clause_35_Shareholding_Pattern_Dec312014.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding pattern under Clause 35 of the Listing Agreement<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.4.2&#8243;][et_pb_text _builder_version=&#8221;4.7.4&#8243; _module_preset=&#8221;default&#8221; text_text_color=&#8221;#000000&#8243; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|700|||||||&#8221; header_3_text_color=&#8221;#000000&#8243; header_3_font_size=&#8221;20px&#8221; header_3_line_height=&#8221;1.2em&#8221;]<\/p>\n<h3><strong>Share Holding 30-9-2014<\/strong><\/h3>\n<p>Note: Kindly note the revised shareholding pattern format<\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/clause_35_shareholding_pattern_sep_30_2014.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding pattern under Clause 35 of the Listing Agreement<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; _builder_version=&#8221;4.7.4&#8243; width=&#8221;90%&#8221; max_width=&#8221;2560px&#8221; custom_padding=&#8221;||0px||false|false&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.4.2&#8243;][et_pb_text _builder_version=&#8221;4.7.4&#8243; _module_preset=&#8221;default&#8221; text_text_color=&#8221;#000000&#8243; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|700|||||||&#8221; header_3_text_color=&#8221;#000000&#8243; header_3_font_size=&#8221;20px&#8221; header_3_line_height=&#8221;1.2em&#8221;]<\/p>\n<h3><strong>Share Holding 31-3-2014<\/strong><\/h3>\n<p>Note: Kindly note the revised shareholding pattern format<\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Clause_35_Shareholding_Pattern_Dec312014.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding pattern under Clause 35 of the Listing Agreement<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.4.2&#8243;][et_pb_text _builder_version=&#8221;4.7.4&#8243; _module_preset=&#8221;default&#8221; text_text_color=&#8221;#000000&#8243; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|700|||||||&#8221; header_3_text_color=&#8221;#000000&#8243; header_3_font_size=&#8221;20px&#8221; header_3_line_height=&#8221;1.2em&#8221;]<\/p>\n<h3><strong>Share Holding 30-6-2014<\/strong><\/h3>\n<p>Note: Kindly note the revised shareholding pattern format<\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Clause_35_Shareholding_Pattern_Dec312014.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding pattern under Clause 35 of the Listing Agreement<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; _builder_version=&#8221;4.7.4&#8243; width=&#8221;90%&#8221; max_width=&#8221;2560px&#8221; custom_margin=&#8221;||||false|false&#8221; custom_padding=&#8221;||0px||false|false&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.4.2&#8243;][et_pb_text _builder_version=&#8221;4.7.4&#8243; _module_preset=&#8221;default&#8221; text_text_color=&#8221;#000000&#8243; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|700|||||||&#8221; header_3_text_color=&#8221;#000000&#8243; header_3_font_size=&#8221;20px&#8221; header_3_line_height=&#8221;1.2em&#8221;]<\/p>\n<h3><strong>Share Holding 31-12-2013<\/strong><\/h3>\n<p>Note: Kindly note the revised shareholding pattern format<\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Clause_35_Shareholding_Pattern_Dec312014.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding pattern under Clause 35 of the Listing Agreement<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.4.2&#8243;][et_pb_text _builder_version=&#8221;4.7.4&#8243; _module_preset=&#8221;default&#8221; text_text_color=&#8221;#000000&#8243; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|700|||||||&#8221; header_3_text_color=&#8221;#000000&#8243; header_3_font_size=&#8221;20px&#8221; header_3_line_height=&#8221;1.2em&#8221;]<\/p>\n<h3><strong>Share Holding 30-9-2013<\/strong><\/h3>\n<p>Note: Kindly note the revised shareholding pattern format<\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/clause_35_shareholding_pattern_sep_30_2014.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding pattern under Clause 35 of the Listing Agreement<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; _builder_version=&#8221;4.7.4&#8243; width=&#8221;90%&#8221; max_width=&#8221;2560px&#8221; custom_padding=&#8221;||0px||false|false&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.4.2&#8243;][et_pb_text _builder_version=&#8221;4.7.4&#8243; _module_preset=&#8221;default&#8221; text_text_color=&#8221;#000000&#8243; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|700|||||||&#8221; header_3_text_color=&#8221;#000000&#8243; header_3_font_size=&#8221;20px&#8221; header_3_line_height=&#8221;1.2em&#8221;]<\/p>\n<h3><strong>Share Holding 30-6-2013<\/strong><\/h3>\n<p>Note: Kindly note the revised shareholding pattern format<\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Clause_35_Shareholding_Pattern_Dec312014.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding pattern under Clause 35 of the Listing Agreement<\/a><\/p>\n<p>[\/et_pb_text][et_pb_text _builder_version=&#8221;4.7.4&#8243; _module_preset=&#8221;default&#8221; text_text_color=&#8221;#000000&#8243; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|700|||||||&#8221; header_3_text_color=&#8221;#000000&#8243; header_3_font_size=&#8221;20px&#8221; header_3_line_height=&#8221;1.2em&#8221;]<\/p>\n<h3><strong>Share Holding 30-6-2013<\/strong><\/h3>\n<p>Note: Kindly note the revised shareholding pattern format<\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Clause_35_Shareholding_Pattern_Dec312014.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding pattern under Clause 35 of the Listing Agreement<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.4.2&#8243;][et_pb_text _builder_version=&#8221;4.7.4&#8243; _module_preset=&#8221;default&#8221; text_text_color=&#8221;#000000&#8243; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|700|||||||&#8221; header_3_text_color=&#8221;#000000&#8243; header_3_font_size=&#8221;20px&#8221; header_3_line_height=&#8221;1.2em&#8221;]<\/p>\n<h3><strong>Share Holding 31-3-2013<\/strong><\/h3>\n<p>Note: Kindly note the revised shareholding pattern format<\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2020\/12\/Clause_35_Shareholding_Pattern_Dec312014.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Shareholding pattern under Clause 35 of the Listing Agreement<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.7.4&#8243; _module_preset=&#8221;default&#8221; da_is_popup=&#8221;off&#8221; da_exit_intent=&#8221;off&#8221; da_has_close=&#8221;on&#8221; da_alt_close=&#8221;off&#8221; da_dark_close=&#8221;off&#8221; da_not_modal=&#8221;on&#8221; da_is_singular=&#8221;off&#8221; da_with_loader=&#8221;off&#8221; da_has_shadow=&#8221;on&#8221; da_disable_devices=&#8221;off|off|off&#8221;][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.7.4&#8243; _module_preset=&#8221;default&#8221; da_is_popup=&#8221;off&#8221; da_exit_intent=&#8221;off&#8221; da_has_close=&#8221;on&#8221; da_alt_close=&#8221;off&#8221; da_dark_close=&#8221;off&#8221; da_not_modal=&#8221;on&#8221; da_is_singular=&#8221;off&#8221; da_with_loader=&#8221;off&#8221; da_has_shadow=&#8221;on&#8221; da_disable_devices=&#8221;off|off|off&#8221;][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>At Sun, we remain committed to creating long term value for our shareholders. In line with this philosophy, we will continue to focus on performance and producing consistent returns.Shareholding PatternShare Holding 31-12-2014 Note: Kindly note the revised shareholding pattern format Shareholding pattern under Clause 35 of the Listing AgreementShare Holding 30-9-2014 Note: Kindly note the [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","inline_featured_image":false,"_uf_show_specific_survey":0,"_uf_disable_surveys":false,"footnotes":""},"class_list":["post-4669","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Ranbaxy Archives | Shareholding Pattern - Sun Pharmaceutical<\/title>\n<meta name=\"description\" content=\"At Sun, we remain committed to creating long term value for Ranbaxy Archives Shareholding Pattern. In line with this philosophy, we will continue to focus on performance and producing consistent returns.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/dev.sunpharma.com\/he\/ranbaxy-merger-share-holding-pattern\/\" \/>\n<meta property=\"og:locale\" content=\"he_IL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ranbaxy Archives | Shareholding Pattern - Sun Pharmaceutical\" \/>\n<meta property=\"og:description\" content=\"At Sun, we remain committed to creating long term value for Ranbaxy Archives Shareholding Pattern. In line with this philosophy, we will continue to focus on performance and producing consistent returns.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/dev.sunpharma.com\/he\/ranbaxy-merger-share-holding-pattern\/\" \/>\n<meta property=\"og:site_name\" content=\"Sun Pharmaceutical Industries Ltd.\" \/>\n<meta property=\"article:modified_time\" content=\"2024-02-15T14:37:13+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 \u05d3\u05e7\u05d5\u05ea\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/dev.sunpharma.com\\\/ranbaxy-merger-share-holding-pattern\\\/\",\"url\":\"https:\\\/\\\/dev.sunpharma.com\\\/ranbaxy-merger-share-holding-pattern\\\/\",\"name\":\"Ranbaxy Archives | Shareholding Pattern - Sun Pharmaceutical\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/dev.sunpharma.com\\\/#website\"},\"datePublished\":\"2020-12-21T18:35:41+00:00\",\"dateModified\":\"2024-02-15T14:37:13+00:00\",\"description\":\"At Sun, we remain committed to creating long term value for Ranbaxy Archives Shareholding Pattern. In line with this philosophy, we will continue to focus on performance and producing consistent returns.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/dev.sunpharma.com\\\/ranbaxy-merger-share-holding-pattern\\\/#breadcrumb\"},\"inLanguage\":\"he-IL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/dev.sunpharma.com\\\/ranbaxy-merger-share-holding-pattern\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/dev.sunpharma.com\\\/ranbaxy-merger-share-holding-pattern\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/dev.sunpharma.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ranbaxy Merger \u2013 Share Holding Pattern\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/dev.sunpharma.com\\\/#website\",\"url\":\"https:\\\/\\\/dev.sunpharma.com\\\/\",\"name\":\"Sun Pharmaceutical Industries Ltd.\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/dev.sunpharma.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"he-IL\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ranbaxy Archives | Shareholding Pattern - Sun Pharmaceutical","description":"At Sun, we remain committed to creating long term value for Ranbaxy Archives Shareholding Pattern. In line with this philosophy, we will continue to focus on performance and producing consistent returns.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/dev.sunpharma.com\/he\/ranbaxy-merger-share-holding-pattern\/","og_locale":"he_IL","og_type":"article","og_title":"Ranbaxy Archives | Shareholding Pattern - Sun Pharmaceutical","og_description":"At Sun, we remain committed to creating long term value for Ranbaxy Archives Shareholding Pattern. In line with this philosophy, we will continue to focus on performance and producing consistent returns.","og_url":"https:\/\/dev.sunpharma.com\/he\/ranbaxy-merger-share-holding-pattern\/","og_site_name":"Sun Pharmaceutical Industries Ltd.","article_modified_time":"2024-02-15T14:37:13+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 \u05d3\u05e7\u05d5\u05ea"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/dev.sunpharma.com\/ranbaxy-merger-share-holding-pattern\/","url":"https:\/\/dev.sunpharma.com\/ranbaxy-merger-share-holding-pattern\/","name":"Ranbaxy Archives | Shareholding Pattern - Sun Pharmaceutical","isPartOf":{"@id":"https:\/\/dev.sunpharma.com\/#website"},"datePublished":"2020-12-21T18:35:41+00:00","dateModified":"2024-02-15T14:37:13+00:00","description":"At Sun, we remain committed to creating long term value for Ranbaxy Archives Shareholding Pattern. In line with this philosophy, we will continue to focus on performance and producing consistent returns.","breadcrumb":{"@id":"https:\/\/dev.sunpharma.com\/ranbaxy-merger-share-holding-pattern\/#breadcrumb"},"inLanguage":"he-IL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/dev.sunpharma.com\/ranbaxy-merger-share-holding-pattern\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/dev.sunpharma.com\/ranbaxy-merger-share-holding-pattern\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/dev.sunpharma.com\/"},{"@type":"ListItem","position":2,"name":"Ranbaxy Merger \u2013 Share Holding Pattern"}]},{"@type":"WebSite","@id":"https:\/\/dev.sunpharma.com\/#website","url":"https:\/\/dev.sunpharma.com\/","name":"Sun Pharmaceutical Industries Ltd.","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/dev.sunpharma.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"he-IL"}]}},"_links":{"self":[{"href":"https:\/\/dev.sunpharma.com\/he\/wp-json\/wp\/v2\/pages\/4669","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dev.sunpharma.com\/he\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/dev.sunpharma.com\/he\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/dev.sunpharma.com\/he\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dev.sunpharma.com\/he\/wp-json\/wp\/v2\/comments?post=4669"}],"version-history":[{"count":26,"href":"https:\/\/dev.sunpharma.com\/he\/wp-json\/wp\/v2\/pages\/4669\/revisions"}],"predecessor-version":[{"id":14956,"href":"https:\/\/dev.sunpharma.com\/he\/wp-json\/wp\/v2\/pages\/4669\/revisions\/14956"}],"wp:attachment":[{"href":"https:\/\/dev.sunpharma.com\/he\/wp-json\/wp\/v2\/media?parent=4669"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}